Sapiens Steering Brain Stimulation GmbH / Sapiens raises € 13m in a Series A financing to fund the development of a novel deep brain stimulation system . Processed and transmitted by Thomson Reuters ...
The FDA's approval was based on results from the 'Intrepid' study, the first multi-center, prospective, double-blind, randomized sham-controlled study of DBS for Parkinson's Disease in the U.S. The ...
For more than twenty years deep brain stimulation (DBS) is being used in patients with movement disorders, predominantly in refractory Parkinson's disease (PD) followed by dystonia and essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results